Clinical Trials Directory

Trials / Completed

CompletedNCT05507255

Effect of Aerobic Exercise on Diurnal Cortisol Pattern in Premenstrual Syndrome

Effect of Aerobic Exercise on Diurnal Cortisol Pattern in Premenstrual Syndrome: A Randomized Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
28 (actual)
Sponsor
Cairo University · Academic / Other
Sex
Female
Age
18 Years – 23 Years
Healthy volunteers
Not accepted

Summary

The aim of this study will be to investigate the effect of aerobic exercise on diurnal cortisol pattern in premenstrual syndrome.

Detailed description

Premenstrual syndrome is manifested by recurrent emotional and depressive symptoms that may be associated with maladaptive coping with stress situations and the enhanced release of stress hormones, like cortisol hormone. Although previous studies revealed a flattened diurnal cortisol slope in women with PMS compared to healthy controls, there is no previous work on the effect of aerobic exercise on diurnal cortisol pattern in premenstrual syndrome. Therefore, this study will aim to investigate the effect of aerobic exercise participation on diurnal cortisol pattern in premenstrual syndrome.This trial will include two groups; group (A) will consist of 14 females who will receive relaxation training for 8 weeks, while group (B) will consist of 14 females who will receive the same relaxation training along with aerobic exercise for 8 weeks.

Conditions

Interventions

TypeNameDescription
OTHERRelaxation trainingRelaxation training in the form of deep breathing exercises
OTHERAn aerobic exercise programAn aerobic exercise program of a moderate intensity, based on the target heart rate (THR) that will be calculated in accordance with Karvonen's equation, using resting heart rate (HRrest), maximal heart rate (HRmax) and training fraction. THR = HRrest (bpm) + (HRmax (bpm) - HRrest (bpm)) × training fraction.The exercise session will have three phases, warming up, active phase and cooling down.

Timeline

Start date
2023-02-01
Primary completion
2023-06-01
Completion
2023-06-01
First posted
2022-08-18
Last updated
2023-06-27

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05507255. Inclusion in this directory is not an endorsement.